[Effectiveness of chemical, herbal and dietetic migraine prophylactis. An overview of randomized controlled double-blind studies].
Diener
H C
HC
Klinik für Neurologie, Universitätsklinikum Essen. hans.diener@uni-duisburg-essen.de
Danesch
U
U
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008274:Magnesium / Q000008:administration & dosage; D008881:Migraine Disorders / Q000209:etiology / Q000517:prevention & control*; D008517:Phytotherapy; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use*; D012256:Riboflavin / Q000009:adverse effects; D000077236:Topiramate
D000318:Adrenergic beta-Agonists; D000927:Anticonvulsants; D000077236:Topiramate; D005632:Fructose; D011433:Propranolol; D008274:Magnesium; D012256:Riboflavin